Target intelligence / Profile preview

Fusobacterium nucleatum outer membrane porin FomA (FomA)

Target
FomA
Molecular classification
Porin, Outer membrane protein, Bacterial adhesin, Beta-barrel protein
01

Overview

Fusobacterium nucleatum outer membrane porin FomA is the primary major outer membrane protein (MOMP) of the Gram-negative anaerobe Fusobacterium nucleatum [1]. It functions as a non-specific porin, forming a 16-stranded beta-barrel structure that facilitates the passive diffusion of small hydrophilic solutes across the outer membrane [2]. Beyond its transport role, FomA acts as a critical adhesin, mediating the co-aggregation of F. nucleatum with other oral bacteria such as Streptococcus species, which is essential for dental plaque biofilm development [3]. In the context of disease, F. nucleatum is strongly associated with periodontitis and the progression of colorectal cancer, where FomA contributes to the bacterium's ability to colonize and persist in the host environment [4]. Research has identified FomA as a promising vaccine candidate due to its high expression and surface exposure, with studies demonstrating that immunization can elicit protective antibody responses [5]. Currently, there are no approved drugs specifically targeting FomA, but it remains a focal point for developing targeted antimicrobials and diagnostic tools for Fusobacterium-associated pathologies [6].

Other names
Major outer membrane protein FomAMOMPPorin FomAFusobacterium nucleatum FomA
02

Mechanism of action

None currently approved; experimental approaches focus on vaccine-induced antibody production to neutralize bacterial colonization or the use of inhibitors to disrupt adhesion and membrane permeability.

03

Biological functions

Passive transport of hydrophilic solutesBacterial co-aggregationBiofilm formationHost cell adhesionImmune modulation
04

Disease associations

PeriodontitisColorectal cancerFusobacteriosisInflammatory bowel disease
05

Safety considerations

Potential disruption of the commensal oral and gut microbiotaRisk of inflammatory response if used as a vaccine antigenImmunological cross-reactivity
06

Biomarkers

Fusobacterium nucleatum DNA levels in stool or tissueAnti-FomA antibody titers

Beyond the preview

Go deeper on Fusobacterium nucleatum outer membrane porin FomA (FomA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fusobacterium nucleatum outer membrane porin FomA (FomA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call